Ponseti-Treated Adults: Long-Term Outcomes, Relapse, Arthritis, and Comparative Effectiveness¶
Last updated: 2026-05-16 Evidence base: 30+ peer-reviewed studies (2011–2026), Oxford CEBM 2011 levels applied throughout ⚠️ Disclaimer: This page synthesises published research for educational purposes. It is not medical advice. Individual outcomes vary; consult a paediatric orthopaedic specialist for clinical decisions.
1. Ponseti Method: Overview and Adoption Timeline¶
The Method¶
The Ponseti method is a minimally invasive, conservative treatment for congenital talipes equinovarus (clubfoot) consisting of three sequential phases:
- Serial manipulation and casting — weekly long-leg plaster casts applied for 5–7 sessions, progressively correcting the deformity by abducting the forefoot under the talus while applying counter-pressure on the lateral talar head
- Percutaneous Achilles tenotomy — performed in ~80–90% of cases to correct residual equinus (PMID 36030649)
- Bracing (foot abduction orthosis) — full-time for 3 months, then nighttime wear for 2–5 years to prevent relapse
Evidence: The Ponseti method achieves initial correction in >90% of idiopathic clubfeet. (Level I — Network meta-analysis of RCTs; PMID 38015923)
Global Adoption Timeline¶
| Period | Milestone |
|---|---|
| 1950s–1963 | Dr. Ignacio Ponseti develops the method at the University of Iowa; publishes his first major series |
| 1963–1995 | Method used primarily at Iowa; limited international uptake; surgical release dominates globally |
| 1995–2000 | Laaveg & Ponseti publish 10-year follow-up data; method gains renewed attention |
| 2000–2005 | Landmark publications demonstrate superior long-term outcomes vs surgical release; adoption accelerates in North America and Europe |
| 2005–2015 | Global dissemination: WHO-endorsed training programmes; adoption in >100 countries, including low- and middle-income countries (LMICs) via Walk for Life and Cure Clubfoot programmes |
| 2015–2026 | Method established as universal gold standard; focus shifts to relapse prevention, long-term adult outcomes, and treatment modifications (accelerated protocols, digital monitoring) |
Evidence: Adoption timeline based on historical narrative reviews and global health programme reports. (Level 5 — Expert opinion; PMID 23685498, 32381310)
2. Relapse Rates by Age at Treatment¶
Relapse (recurrence of any component of deformity after initial correction) remains the most significant long-term problem after Ponseti treatment. Rates vary substantially by study, follow-up duration, and definition of relapse.
Summary of Relapse Rates¶
| Study | Design (CEBM Level) | N | Follow-up | Relapse Rate | Key Risk Factors |
|---|---|---|---|---|---|
| PMID 34415418 (2021) | Systematic review of 14 studies (Level I) | 774 patients / 1,122 feet | Mean 14.5 years | 47% | Longer follow-up increases relapse detection; 79% of relapsed patients needed additional surgery |
| PMID 35081931 (2022) | Retrospective cohort (Level III) | 148 cases (164 ft) | 5–10 years | 21.6% | Brace noncompliance (OR significant, p<0.05), higher initial Pirani score, younger age at first casting |
| PMID 34423014 (2021) | Narrative review (Level V) | Multiple studies | Variable | Up to 40% | No consensus definition of relapse; wide range across studies |
| PMID 33633502 (2020) | Multi-centric prospective (Level III) | 429 feet in 303 patients | Median 1.3 years | ~15–20% (varies by age group) | Older age at treatment (>1 year) associated with higher relapse in neglected clubfoot |
| PMID 40061846 (2025) | Retrospective cohort (Level III) | 107 children (152 feet) | >10 years | Reduced with modified bracing | Shorter night-splinting (2 years vs 6 years) showed similar recurrence in compliant patients |
Age-Specific Relapse Patterns¶
- Neonatal treatment (<1 month): Relapse rates of 15–25% at 5-year follow-up; highest risk period is 2–5 years during rapid growth (PMID 35081931; Level III)
- Infantile treatment (1–6 months): Similar initial correction rates; relapse rates comparable to neonatal group when bracing compliance is maintained (PMID 41757814; Level I systematic review)
- Late/walking-age treatment (>1 year): Higher relapse rates, estimated 25–35%, particularly in the first 2 years after correction (PMID 33633502; Level III)
- Neglected clubfoot (adolescent/adult): Limited data; case reports show successful initial correction even at age 26, but long-term relapse risk is poorly characterised (PMID 33623773; Level 5 — Case report)
Brace Noncompliance as the Primary Modifiable Risk Factor¶
The single strongest predictor of relapse is noncompliance with the foot abduction brace. In one cohort, the noncompliance rate was 33.1%, and relapse was significantly higher in this group (PMID 35081931; Level III). Transportation barriers, socioeconomic disadvantage, and lower Child Opportunity Index are associated with treatment delays and higher relapse risk (PMID 42012355; Level III).
Evidence: Relapse data synthesised from one Level I systematic review, multiple Level III cohorts, and Level V narrative reviews. The 47% figure from the longest-follow-up systematic review (PMID 34415418) likely reflects detection of late relapses that shorter studies miss.
3. Repeat Casting and Additional Surgery Rates¶
Repeat Casting for Relapse¶
Recurrent deformity after initial Ponseti correction is commonly managed with repeat serial casting before considering surgery. This approach is supported by evidence that repeat Ponseti management can produce gait outcomes comparable to feet that never relapsed (PMID 31815859; Level III).
| Approach | Evidence | Outcome |
|---|---|---|
| Repeat Ponseti casting for early relapse | PMID 31815859 (Level III): 25 relapsed feet vs 28 non-relapsed feet; gait analysis | No significant difference in kinematic parameters between groups (p>0.05); repeat Ponseti recommended as first-line for relapse |
| Relapse after Kite vs Ponseti technique | PMID 32412098 (Level I, Cochrane review) | Relapse after Kite technique more often led to major surgery (risk difference 25–50%); Ponseti relapse more amenable to repeat casting |
| Narrative review of relapse management | PMID 34423014 (Level V) | Repeat casting ± tendo-Achilles lengthening, plantar fascia release, and tibialis anterior tendon transfer (TATT) all described; no consensus algorithm |
Additional Surgery Rates¶
The long-term systematic review (PMID 34415418; Level I) found that of the 47% who relapsed, 79% required additional surgery: - 86% of additional surgeries were extra-articular (e.g., tibialis anterior tendon transfer, repeat tenotomy) - 14% were intra-articular (e.g., osteotomies, joint-involving procedures)
In the landmark 15-year prospective comparison (PMID 34547011; Level II): - 42% of Ponseti-treated feet (16/38) required a further surgical procedure - 48% of PMR-treated feet (20/42) required further surgery - However, PMR-treated feet were significantly more likely to require osteotomies and intra-articular procedures (15 vs 5 feet, p<0.05)
Tibialis Anterior Tendon Transfer (TATT)¶
TATT is the most common secondary procedure after Ponseti treatment, addressing dynamic supination in relapsed feet. A multicentre comparison of three TATT fixation techniques (pull-through button, interference screw, suture anchor) showed comparable outcomes (PMID 40700431; Level III).
Evidence: Surgery rates from one Level I systematic review and one Level II prospective cohort. The distinction between extra-articular and intra-articular surgery is clinically important, as intra-articular procedures carry greater risk of stiffness and degenerative changes.
4. Late Arthritis Rates in Ponseti-Treated Adults¶
Arthritis After Ponseti Treatment¶
Long-term radiological follow-up of Ponseti-treated feet reveals that degenerative changes are common even when clinical function is good:
| Finding | Rate | Source (CEBM Level) |
|---|---|---|
| Talar flattening (talar dome deformity) | 60% | PMID 34415418 — Systematic review, 14 studies (Level I) |
| Navicular wedging/subluxation | 76% | PMID 34415418 (Level I) |
| Degenerative osteoarthritis changes | 30% | PMID 34415418 (Level I) |
| Flat-top talus | Present in both Ponseti and surgical groups; Ponseti more protective (RR=0.494, p=0.002) | PMID 32982254 (Level III) |
Arthritis in the Broader Clubfoot Population (Non-Ponseti Era Treatments)¶
A study of 60 patients (89 feet) at >60 years follow-up (mean age 64 years), treated before the Ponseti era with various methods, found: - Severe ankle OA: 8% of feet - Severe talonavicular OA: 12% of feet - The ankle joint was described as "relatively resistant to the development of osteoarthritis" - Patients with ≥2 surgical procedures had significantly worse functional outcomes (p<0.001) - Medial subluxation of the navicular correlated with worse function (p<0.001)
(PMID 23109633; Level III — Case-control with radiographic assessment)
Ponseti vs Surgical Treatment: Arthritis Comparison¶
The critical adult-outcome comparison (PMID 24249539; Level III — Case-control, mean follow-up ~25 years) found: - The Ponseti group had a decreased incidence of osteoarthritis in the ankle and foot compared to the comprehensive surgical release group - Both groups had diminished strength and motion vs controls - The Ponseti group had greater ankle plantar flexion ROM (p<0.001), greater plantar flexor strength (p=0.031), and greater evertor strength (p=0.012) than the surgical group - During gait, the surgical group had reduced peak ankle plantar flexion (p=0.002) and reduced sagittal plane ROM (p=0.008–0.009) - Elevated pain levels in the surgical group (p=0.008)
Clinical Implications¶
Despite the high prevalence of radiological degenerative changes (30–76%), the majority of Ponseti-treated feet remain plantigrade and functionally well into adulthood. The disconnect between radiological findings and clinical function is a consistent theme: - Good clinical outcome scores despite abnormal radiographic angles - Most patients are high-functioning into early adulthood - Pain levels are generally lower in Ponseti-treated vs surgically treated patients
Evidence: Arthritis data from one Level I systematic review (PMID 34415418), one Level II prospective comparison (PMID 34547011), and two Level III case-control studies (PMID 23109633, 24249539). The long-term arthritis burden in Ponseti-treated patients specifically (rather than mixed-era treatments) remains incompletely characterised, as most Ponseti cohorts have not yet reached the age when degenerative arthritis typically manifests (age 50+).
5. Comparative Adult Outcomes: Ponseti vs PMR vs French Method¶
5.1 Ponseti vs Posteromedial Release (PMR)¶
15-Year Prospective Comparison (PMID 34547011; Level II)¶
This is the highest-quality comparative study to date — a prospective cohort of 51 patients followed to a median of 15 years (range 13–17 years), with multimodal assessment including patient-reported outcomes, clinical examination, 3D gait analysis, and plantar pressures.
| Outcome Measure | Ponseti (n=38 ft) | PMR (n=42 ft) | p-value |
|---|---|---|---|
| Dimeglio score (lower = better) | 5.8 | 7.0 | <0.05 |
| Disease Specific Instrument | 80.7 | 65.6 | <0.05 |
| Functional Disability Inventory | 1.1 | 5.1 | <0.05 |
| AAOS Foot & Ankle Questionnaire | 52.2 | 46.6 | <0.05 |
| Additional surgery (any type) | 42% | 48% | NS |
| Osteotomies/intra-articular surgery | 5 feet | 15 feet | <0.05 |
| Total sagittal ankle ROM in gait | Better | Reduced | — |
Conclusion: The Ponseti group demonstrated superior functional outcomes across multiple domains. Although reoperation rates were similar, the PMR group required more invasive (intra-articular) procedures.
Adolescent Follow-Up (PMID 32982254; Level III)¶
At mean follow-up of ~13 years: - Ponseti: 76% excellent/good results (ICFSG score) - PMR: 45% excellent/good results - Ponseti superior in total ICFSG score (10.58 ± 6.49 vs 17.26 ± 8.83, p<0.001), functional score (p<0.001), and radiological score (p<0.001) - Flat-top talus less frequent with Ponseti (relative risk 0.494, p=0.002) - Overall foot/ankle mobility significantly better in Ponseti group (p<0.001)
Adult Comparison at ~25 Years (PMID 24249539; Level III)¶
Compared 42 adults (24 surgical, 18 Ponseti) and 48 controls: - Ponseti group: greater ROM, greater strength, less arthritis than surgical group - Both clubfoot groups: reduced strength, ROM, and quality of life vs controls - Pain levels: surgical group > Ponseti group (p=0.008) - Ankle power generation: surgical group had lowest values (p=0.002 vs controls)
Long-Term PMR Outcomes (PMID 20864856; Level III)¶
In 58 clubfeet followed for mean 16 years after PMR: - 26% excellent, 29% good, 22% poor — indicating significant long-term stiffness - Dorsiflexion decreased by 31%, pronation-supination decreased by 24% - Osteoarthritis grade consistently higher in clubfeet vs contralateral normal feet - 9% needed additional bony procedures for pain/overcorrection (considered treatment failure)
5.2 Ponseti vs French Functional Method¶
Systematic Review (PMID 34020862; Level I)¶
A systematic review of seven studies (2008–2018) comparing Ponseti and French methods concluded: - "It is impossible to affirm [Ponseti's] superiority over the functional method" - Each method has advantages the other lacks (morphological vs kinetic criteria) - Suggested a hybrid method combining advantages of both as a future prospect
10-Year Functional Outcomes (PMID 30516624; Level III)¶
At age 10, children initially treated nonoperatively (Ponseti or French) were compared with those requiring subsequent surgery: - Nonoperative group (n=148 feet): better ankle kinetics and isokinetic strength - Intra-articular surgery group (n=86 feet): significant deficits in ankle power and strength (p<0.017 vs nonoperative) - All clubfoot groups vs controls (n=40): reduced ankle plantar flexion (9–14% deficit in ROM, 13–20% in moment, 13–23% in power; p<0.013) - Clubfoot patients took 10% fewer steps (p=0.015) and had 11% less ambulatory time (p=0.001) than controls - Parents perceived no functional differences despite measurable deficits
French Method at 20 Years (PMID 33741833; Level IV)¶
In 145 children (210 clubfeet) treated with the French functional method over 20 years: - <15% required surgery at walking age - 80% good/excellent results without major residual deformity at final follow-up - 7% required later intervention for recurrence or major residual deformity - Higher compliance than Ponseti method reported - Higher cost and difficulty of application in developing countries cited as disadvantages - Requires a well-trained physiotherapist available for daily sessions
5.3 Network Meta-Analysis: All Methods (PMID 38015923; Level I)¶
A network meta-analysis of 11 RCTs (740 feet) comparing Ponseti, accelerated Ponseti, Ponseti + Botox, Ponseti + early TATT, Kite method, and surgical treatment:
| Outcome | Best-Ranking Intervention (SUCRA) |
|---|---|
| Pirani score improvement | Ponseti method |
| Maximal ankle dorsiflexion | Ponseti method |
| Fewest casts | Ponseti method |
| Fewest adverse events | Ponseti method |
| Fewest total complications | Ponseti method |
| Shortest time in casts | Accelerated Ponseti |
| Lowest tenotomy rate | Accelerated Ponseti |
| Lowest relapse rate | Early TATT |
| Lowest need for major surgery | Ponseti + Botox |
Conclusion: The standard Ponseti method ranked best overall despite potential drawbacks of longer casting time and higher tenotomy/relapse rates compared to modified approaches.
5.4 Comparative Summary Table¶
| Outcome Domain | Ponseti | PMR (Surgical) | French Method |
|---|---|---|---|
| Initial correction rate | >90% | >90% | >85% |
| Long-term relapse | 22–47% | Variable (relapses manifest differently) | <15% need surgery at walking age |
| Additional surgery rate | 42–79% (mostly extra-articular) | 48% (more intra-articular) | 7–15% |
| Adult ROM | Better than PMR | Significantly reduced | Insufficient long-term adult data |
| Adult arthritis | 30% degenerative changes | Higher incidence | Insufficient data |
| Pain levels | Lower than surgical | Higher than Ponseti | Insufficient adult data |
| Functional scores (adult) | Superior to PMR | Inferior to Ponseti | Comparable to Ponseti at 10 years |
| Compliance demands | Moderate (bracing) | N/A (one-time surgery) | High (daily therapy) |
| Cost/resource needs | Low | High (OR, anaesthesia) | High (daily physiotherapy) |
| Applicability in LMICs | Excellent | Limited | Limited |
Evidence: Comparative data from one Level I network meta-analysis, one Level I systematic review, one Level II prospective cohort, and multiple Level III retrospective studies. Direct Ponseti-vs-French comparison at adult ages remains unavailable.
6. Current Active Clinical Trials Tracking Ponseti Cohorts¶
Recruiting or Active Trials (as of May 2026)¶
| NCT Number | Title | Status | Start Date | Focus |
|---|---|---|---|---|
| NCT06906406 | Health-Related Quality of Life in Children and Adolescents With Clubfoot | RECRUITING | 2025-01 | HRQoL in ages 2–15 years treated by Ponseti; PedsQL 4.0 assessment |
| NCT07554092 | Comparison of Radiological Outcome of Conventional vs Accelerated Ponseti Casting | RECRUITING | 2026-02 | Radiological comparison of standard vs accelerated Ponseti protocols |
Recently Completed Trials¶
| NCT Number | Title | Status | Start Date | Relevance to Adult Outcomes |
|---|---|---|---|---|
| NCT07249684 | Myofascial Release and Static Stretching Along With Nighttime Bracing | COMPLETED | 2025-11 | Relapse prevention strategy; long-term bracing protocol |
| NCT06407739 | Three Phase Physical Therapy for Relapsed Clubfoot After Ponseti Treatment | COMPLETED | 2024-05 | Physiotherapy for post-Ponseti relapse management |
| NCT02022267 | Gait Analysis in Ponseti Clubfoot | COMPLETED | 2011-10 | Functional gait assessment (10+ year data potentially available) |
| NCT01551264 | Duration of Brace Wear in Clubfoot Treatment — Prospective Randomized Trial | COMPLETED | 2012-05 | Optimal bracing duration; direct relapse implications |
| NCT04766684 | Clubfoot Tenotomy Trial | COMPLETED | 2021-06 | Tenotomy technique comparison |
| NCT01088828 | MRI Exploration of Clubfoot Causes | COMPLETED | 2010-05 | Pathoanatomical understanding of deformity |
Trial Gaps¶
No currently recruiting trial specifically tracks adult outcomes (age >18 years) in Ponseti-treated cohorts. The longest prospective functional outcome studies (PMID 34547011, PMID 30516624) have followed patients to median ages of 15 and 10 years, respectively. Dedicated adult-outcome registries and prospective cohorts extending to age 30+ are needed.
Evidence: Trial data retrieved from ClinicalTrials.gov (api.v2) on 2026-05-16. (Level 5 — Registry data)
7. Key Outstanding Questions¶
- What are the true adult (>25 years) functional outcomes of Ponseti-treated feet? — Current longest follow-up is median 15 years (PMID 34547011). No prospective Ponseti cohort has been followed to age 30+.
- Does the 30% rate of degenerative changes progress to symptomatic osteoarthritis? — The disconnect between radiological OA and clinical function needs longer follow-up.
- Can the 47% long-term relapse rate be reduced? — Brace compliance interventions, digital exercise programmes (PMID 41250053; RCT protocol), and modified bracing protocols are under investigation.
- Is the French method truly equivalent? — Systematic review (PMID 34020862) found no clear superiority of either method, but direct comparison at adult ages is lacking.
- What is the optimal bracing duration? — Standard recommendation is 2–5 years; some evidence suggests shorter protocols may be adequate in compliant patients (PMID 40061846).
8. References¶
| PMID | Year | Authors (first 3) | Title | Journal | CEBM Level |
|---|---|---|---|---|---|
| 38015923 | 2024 | — | Determining the Optimal Treatment for Idiopathic Clubfoot: A Network Meta-Analysis of RCTs | J Bone Joint Surg Am | I |
| 34415418 | 2021 | — | Long-term outcomes of the Ponseti method: a systematic review | Int Orthop | I |
| 32412098 | 2020 | — | Interventions for congenital talipes equinovarus (Cochrane review) | Cochrane Database Syst Rev | I |
| 34020862 | 2021 | — | Ponseti vs French functional method: systematic review | Arch Pediatr | I |
| 41570857 | 2026 | — | Ponseti method in Africa: systematic review and meta-analysis | Bone Joint Open | I |
| 41549019 | 2026 | — | Accelerated vs standard Ponseti: systematic review and meta-analysis | Foot Ankle Surg | I |
| 34547011 | 2021 | — | Prospective 15-year comparison of Ponseti casting vs surgical treatment | J Bone Joint Surg Am | II |
| 35081931 | 2022 | Hu W, Ke B, Niansu X et al. | Factors associated with relapse in Ponseti-treated clubfoot | BMC Musculoskelet Disord | III |
| 32982254 | 2022 | — | PMR vs Ponseti: long-term follow-up into adolescence | Ther Clin Risk Manag | III |
| 24249539 | 2014 | — | Comprehensive clubfoot release vs Ponseti: long-term results | Clin Orthop Relat Res | III |
| 23109633 | 2013 | — | Low prevalence of OA in clubfoot at >60 years follow-up | J Bone Joint Surg Br | III |
| 31599864 | 2020 | Graf AN, Kuo KN et al. | Foot morphology and pain in young adults with clubfoot | J Pediatr Orthop | III |
| 31815859 | 2020 | — | Repeated Ponseti for relapsed clubfeet: gait analysis | J Pediatr Orthop | III |
| 32658394 | 2020 | — | Plantar pressures: posterior release vs PMR vs nonoperative | J Pediatr Orthop | III |
| 30516624 | 2019 | — | Functional outcomes at 10 years: Ponseti vs French vs surgery | J Bone Joint Surg Am | III |
| 33633502 | 2020 | de Podesta Haje D et al. | Ponseti after walking age: 429 feet multicentric study | Iowa Orthop J | III |
| 41867394 | 2026 | Donzelli A et al. | EFAS score in skeletally mature Ponseti-treated patients | J Child Orthop | III |
| 40396381 | 2025 | — | 10-year functional outcome: idiopathic vs arthrogrypotic clubfeet | J Pediatr Orthop | III |
| 42012355 | 2026 | — | Transportation barriers and relapse risk | J Am Acad Orthop Surg | III |
| 20864856 | 2011 | — | Long-term results of PMR (16-year follow-up) | J Pediatr Orthop | III |
| 33741833 | 2022 | — | 20 years of French functional method vs Ponseti | J Pediatr Orthop B | IV |
| 36037761 | 2022 | — | Clinical/radiological/pedobarographic outcomes of Ponseti | Foot | IV |
| 33623773 | 2022 | Haje DP et al. | Neglected clubfoot in 26-year-old adult: case report | J Orthop Case Rep | V |
| 34423014 | 2021 | — | Narrative review: management of relapsed clubfoot | Ann Transl Med | V |
| 23685498 | 2014 | — | Clubfoot treatment through the ages | Der Orthopade | V |
| 32381310 | 2021 | — | Correction of neglected clubfoot in adolescent/adult | Foot Ankle Clin | V |
Appendix: Oxford CEBM 2011 Evidence Levels¶
| Level | Study Design |
|---|---|
| 1a | Systematic review of RCTs (with homogeneity) |
| 1b | Individual RCT (with narrow confidence interval) |
| 2a | Systematic review of cohort studies (with homogeneity) |
| 2b | Individual cohort study / low-quality RCT |
| 3a | Systematic review of case-control studies |
| 3b | Individual case-control study |
| 4 | Case series (and poor-quality cohort/case-control studies) |
| 5 | Expert opinion without explicit critical appraisal, or based on physiology, bench research, or "first principles" |